Recently, Freed-Pastor et al.22 have described that the mutant p53 is recruited at the promoters of sterol genes by SREBPs to upregulate the expression of the sterol biosynthesis enzymes in human breast cancer cells. This evidence concerns the gene TP53 and breast cancer.